CANC broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 22 similar instances where the stock broke above the upper band. In 20 of the 22 cases the stock fell afterwards. This puts the odds of success at 90%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CANC as a result. In 48 of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CANC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence (MACD) for CANC just turned positive on October 20, 2026. Looking at past instances where CANC's MACD turned positive, the stock continued to rise in 28 of 28 cases over the following month. The odds of a continued upward trend are 90%.
CANC moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CANC crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +6.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where CANC advanced for three days, in 174 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Aroon Indicator entered an Uptrend today. In 140 of 155 cases where CANC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The RSI Indicator for IDYA moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 32 of the 33 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 63 cases where IDYA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for IDYA just turned positive on November 11, 2026. Looking at past instances where IDYA's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.
Following a +4.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDYA advanced for three days, in 217 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
IDYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IDYA as a result. In 81 of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDYA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for IDYA entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.514) is normal, around the industry mean (3.498). P/E Ratio (-16.271) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (14.409) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. IDYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
IDYA | ||
|---|---|---|
OUTLOOK RATING 1..100 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 80 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 30 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CANC | IDYA | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 88% | 2 days ago 73% |
| Momentum ODDS (%) | 2 days ago 84% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 85% |
| Advances ODDS (%) | 4 days ago 87% | 4 days ago 75% |
| Declines ODDS (%) | 2 days ago 83% | 10 days ago 76% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 84% |
A.I.dvisor indicates that over the last year, CANC has been loosely correlated with IMNM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CANC jumps, then IMNM could also see price increases.
| Ticker / NAME | Correlation To CANC | 1D Price Change % | ||
|---|---|---|---|---|
| CANC | 100% | -0.91% | ||
| IMNM - CANC | 64% Loosely correlated | +2.25% | ||
| IDYA - CANC | 59% Loosely correlated | +3.04% | ||
| KURA - CANC | 59% Loosely correlated | +2.11% | ||
| RVMD - CANC | 57% Loosely correlated | -6.40% | ||
| IMCR - CANC | 56% Loosely correlated | -2.25% | ||
More | ||||
A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RNA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RNA could also see price increases.
| Ticker / NAME | Correlation To IDYA | 1D Price Change % | ||
|---|---|---|---|---|
| IDYA | 100% | +3.04% | ||
| RNA - IDYA | 48% Loosely correlated | -3.28% | ||
| SLDB - IDYA | 47% Loosely correlated | +6.00% | ||
| EDIT - IDYA | 45% Loosely correlated | -4.99% | ||
| DYN - IDYA | 44% Loosely correlated | +0.39% | ||
| MGTX - IDYA | 44% Loosely correlated | +0.62% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AGEM | 45.55 | 1.17 | +2.63% |
| abrdn Emerging Markets Dividend Active ETF (AGEM) | |||
| LDRH | 23.96 | 0.01 | +0.04% |
| iShares iBonds 1-5 Year High Yield and Income Ladder ETF | |||
| QQQX | 30.68 | N/A | N/A |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | |||
| FLSW | 44.69 | -0.36 | -0.80% |
| Franklin FTSE Switzerland ETF (FLSW) | |||
| CGRO | 16.35 | -0.27 | -1.61% |
| CoreValues Alpha Greater China Growth ETF (CGRO) | |||